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Abstract
Aspergillus fumigatus is a major airborne nosocomial pathogen that is responsible for
severe mycosis in immunocompromised patients. We studied the efficacy of an innova-
tive mobile air-treatment device in eliminating A. fumigatus from the air following ex-
perimental massive contamination in a high-security room. Viable mycological particles
were isolated from sequential air samples in order to evaluate the device’s effectiveness
in removing the fungus. The concentration of airborne conidia was reduced by 95% in 18
min. Contamination was reduced below the detection threshold in 29min, even when the
machine was at the lowest airflow setting. In contrast, during spontaneous settling with
no air treatment, conidia remained airborne for more than 1 h. This indoor air contamina-
tion model provided consistent and reproducible results. Because the air purifier proved
to be effective at eliminating a major contaminant, it may prove useful in preventing
air-transmitted disease agents. In an experimental space mimicking a hospital room, the
AirLyse air purifier, which uses a combination of germicidal ultraviolet C irradiation and
titanium photocatalysis, effectively eliminated Aspergillus conidia. Such a mobile device
may be useful in routine practice for lowering microbiological air contamination in the
rooms of patients at risk.
Key words: Aspergillus, indoor air contamination, nosocomial infections, photocatalysis, titanium, mobile air purifier.
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Introduction
The incidence of nosocomial mycosis is increasing rapidly
[1]. Airborne transmission is the major route of contam-
ination, especially to immunocompromised patients [2,3]
and patients taking corticosteroids [4]. Various moulds, in
particular Aspergillus fumigatus, are widespread and ex-
tremely virulent in this opportunistic context [5,6]; invasive
aspergillosis is associated with high mortality rates [3]. The
use of antifungal drugs is limited by high costs cost and side
effects [7].
The relationship between the presence of Aspergillus
in the air and outbreaks of nosocomial aspergillosis has
been clearly demonstrated [8,9], and this has led to im-
plementation of various air-quality controls [10]. A va-
riety of technological processes have been used to treat
air, including high-efficiency particulate air (HEPA) filtra-
tion and air pressure regulation [11]; however, all have
been found to have technical limitations. Indeed, filtra-
tion no longer appears to be the best air-treatment pro-
cess because it consumes energy and may result in the ac-
cumulation of pollutants that could be released into the
air [12]. There are also problems with the growth of mi-
crobiological agents on the filter [13]. Consequently, new
and innovative technologies are needed to improve air
quality [14].
The development of the AirLyse AL-PR004 prototype
was hosted in the medical school of Tours Franc¸ois-
Rabelais University, France, in collaboration with industry.
This patented device is a mobile stand-alone air purifier
designed for continuous decontamination of indoor air in
the presence of humans [15]. In contrast with existing fil-
tration systems, the AirLyse air purifier does not have a
retention function; rather, it destroys airborne particles in
the ambient air. The purifier combines physical inactivation
of organic residues and germicidal treatment using ultravi-
olet C (UVC at wavelengths of 200–290 nm) with destruc-
tion by titanium dioxide (TiO2) photocatalysis [16]. TiO2
photocatalysis is stable and energy efficient and has been
proven to completely mineralize organic pollutants present
in air and water [17] into nontoxic substances, primarily,
mineral acids, carbon dioxide, and water [18]. The pho-
tocatalytic degradation process involves the production of
very reactive but short-lived hydroxyl oxidants; the reac-
tive oxygen species that are generated are directly reduced.
Unlike the activated carbon, the titanium oxide is not con-
sumed by the photocatalytic reaction, therefore allowing
a continuous functioning [19]. This type of photocataly-
sis has been shown to effectively destroy a wide range of
gram-negative and gram-positive bacteria, filamentous and
unicellular fungi, algae, protozoa, mammalian viruses, and
bacteriophages [17].
Among the various devices that are based on photocat-
alytic technology, the AirLyse air purifier is quite innova-
tive, particularly in terms of its three-dimensional confor-
mation, which makes it possible to treat large volumes of
air. It is also convenient to use because of its mobile “plug-
and-play” system, which was specifically developed for use
in diverse healthcare facilities.
Here, we report on the development of an experimen-
tal model of Aspergillus environmental contamination. We
then assess the AirLyse air purifier’s ability to remove A. fu-
migatus by measuring airborne conidia concentrations and
comparing the results with those of spontaneous settling
over time. This study was authorized by INRA (Institut Na-
tional de la Recherche Agronomique) and La Re´gion Centre
and was performed in accordance with the principles of the
Helsinki declaration.
Materials and methods
Experimental model of Aspergillus contamination
Decontamination tests were performed in a 60 m3 (5 ×
4 × 3 m) high-security (safety level L3) room at the In-
stitut National de la Recherche Agronomique, Nouzilly,
France (Fig. 1). The room’s heating, ventilation, and air-
conditioning (HVAC) system allowed input and output air
to be fully HEPA-filtered before and after the experiments.
However, HEPA filtration was completely stopped dur-
ing tests to avoid any airflow exchange with the outside.
Between experiments, the inside air was totally renewed
through the HVAC system (a process known as washout).
Throughout testing, the room’s temperature and hygrome-
try were verified. Operators inside the experimental room
wore sterile protective clothing and respirators to provide
complete protection against exposure to microbiological
agents.
At T0 (the time of nebulization), a dose of 107 A. fu-
migatus conidia was aerosolized in a single step through a
central commercial jet nebulizer (Atomisor+/NL9M, cou-
pled to an Abox+ compressor; La Diffusion Technique
Franc¸aise, Saint-Etienne, France) placed 1.6 m above the
floor at the center of the room [20]. Four mobile stand-
ing fans were distributed in a circle with a radius of 140
cm around the nebulizer. The fans were started concomi-
tantly with the Aspergillus nebulization and ran for 4 min
to distribute airborne particles throughout the room.
Inoculum preparation
The A. fumigatus strain used for the experimental contami-
nation was isolated from a patient with proven aspergillosis
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Figure 1. Setup of the room for experimental Aspergillus contamination. The upper panel shows a detailed map of the aerosolization room.
Experimental procedures required a central nebulization device (N), a mobile air-treatment unit (AirLyse air purifier), four bio-impactors (BI) for air
sampling, one portable particle counter (PC), and four fans (Fan). The lower panel is a photo of the biosafety level-3 facility; it shows an operator
wearing a protective suit fitted with a respirator. This Figure is reproduced in color in the online version of Medical Mycology.
and hospitalized in the oncology–hematology department
of Tours University Hospital (France). The strain is regis-
tered as no. BRFM 1827 (Banque de Ressources Fongiques
de Marseille) in the World Federation for Culture Col-
lections - Microbiological Resources Centres collection of
the World Data Centre for Microorganisms (CIRM–UMR
1163 INRA, Marseille, France). The strain was plated on
Sabouraud agar (SabouraudGM+C; Becton Dickinson, Le-
Pont-de-Claix, France) and incubated at 37◦C for 5 days.
Conidia were harvested by flooding the Aspergillus plate
with 15 ml of a sterile solution of 0.05% Triton X100
(ICN Biomedicals, Irvine, CA, USA) in 0.9% phosphate-
buffered saline (PBS; bioMe´rieux, Craponne, France). The
suspension was collected by aspiration and centrifuged at
1700 g for 10 min. The supernatant was discarded and the
pellet recovered in 50 ml PBS, and the centrifugation cycle
was repeated (1700 g for 10 min). The conidia concentra-
tion was assessed in a Malassez counting chamber (Kova
Slide 10; Glasstic, Garden Grove, CA, USA) and adjusted
at 107 conidia/ml by dilution in PBS.
Assessment of different operating modes
of the AirLyse air purifier
The AirLyse AL-PR004 prototype was tested in the experi-
mental conditions described above. According to American
National Standards Institute/Association of Home Appli-
ance Manufacturers document AC-1-2002 [21], indepen-
dent trials were run at the following airflows: 0 m3/h (ma-
chine turned off to allow spontaneous settling), 500 m3/h,
600 m3/h, and 1000 m3/h (machine turned on throughout
each trial period).
Air sampling
Mycological samples were sequentially collected from air
during every experimental procedure in order to establish
the kinetics of changes in the airborne conidia concentra-
tion. Four bio-impactors (MK2 Sampl’AIR; AES Chemu-
nex, Cranbury, NJ, USA) were placed 1.4 m away from
the source of Aspergillus conidia and 1.2 m above the
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floor (Fig. 1). The aspirated air was projected by each bio-
impactor toward a malt extract agar plate (25 g malt ex-
tract, 20 g agar, 1 l water) through a grid a few millimeters
above the plate. At the start of each sampling period, the
bio-impactors were simultaneously turned on with a remote
control; 200 l of air was sample for 2 min [22]. Baseline
samples were collected at T0, when the air purifier was off;
samples were then collected for 2min at T5, T10, T15, T20,
T30, T45, and T60. One hour after nebulization (T60), the
fans were restarted for 5 min to redistribute any conidia
that had settled on surfaces and the air was sampled at
T75. A Solair 5350 portable particle counter (Lighthouse,
Fremont, CA, USA) was used for instantaneous and con-
tinuous counting of total airborne particles during the ex-
periment. The read channel that measured particles larger
than 1 µm was selected in view of the size of A. fumigatus
conidia (2–3 µm).
Air-quality analysis
The malt extract agar plates were analyzed at the
Parasitology–Mycology–Tropical Medicine Department,
University Hospital of Tours (France). After 48 h of in-
cubation at 37◦C, the number of A. fumigatus conidia was
determined for each air sample and expressed as colony-
forming units (CFU)/200 l of air. Because of the number
of holes in the grid placed above the plates during collec-
tion, the maximum count for any one Petri dish was n =
258 CFU/200 l. However, a count of 1 CFU may be the
result of the entry of one or more conidia through the same
hole in the grid; therefore, the total number of CFUs was
adjusted according to a nomogram supplied by the man-
ufacturer (Chemunex) in order to provide a more reliable
count. This involved use of an algorithmic graphical calcu-
lating device to account for the statistical probability of at
least two conidia having been collected at one position. By
fixing the values of CFU variables according to Chemunex’s
instructions, the relationship between the unfixed variables
could thus be studied; a predefined table was used to obtain
the corrected value N (estimated number of viable conidia
impacting the plate) corresponding to the observed value n
(number of CFU observed experimentally). Whenever mea-
surements were concordant, the meanN was calculated for
the four malt extract agar plates used concomitantly.
Statistical analysis
The intraclass correlation coefficient was calculated to as-
sess concordance between the four bio-impactors using the
respective N values at each sampling time. The exponential
decays of the mean values of N were modeled for each rate
of airflow using the following differential equation:N (T) =
Figure 2. AirLyse air purifier efficiency against massive Aspergillus con-
tamination. The modeling of N means (colony-forming units [CFU]/200
l) for each airflow speed is presented as N (t) = N0e−λt. Gray curve, con-
ditions of spontaneous decrease with the AirLyse purifier off at 0 m3/h;
green curve, conditions with the AirLyse purifier on at 500 m3/h; blue
curve, the AirLyse purifier on at 600 m3/h; and red curve, the AirLyse
purifier on at 1000 m3/h. This Figure is reproduced in color in the online
version of Medical Mycology.
N0e−λT, where coefficient λ is a positive number, named the
decay constant. The λ coefficient for each airflow rate was
then compared with each other λ and with that for the con-
trol condition (spontaneous settling with no air treatment)
using Student t test.
Results
A total of 36 sequential air samples, corresponding to four
replicates (the four bio-impactors) at each of nine time
points, were analyzed for the following four conditions:
negative reference condition at 0 m3/h (AirLyse air purifier
off) and active air treatment at 500 m3/h, 600 m3/h, and
1000 m3/h (AirLyse on). The four bio-impactors gave very
similar results. The intraclass correlation coefficients were
as follows: 0.987 (0.967–0.996) at 0 m3/h, 0.998 (0.996–
1.0) at 500 m3/h, 0.998 (0.996–1.0) at 600 m3/h, and 0.994
(0.984–0.998) at 1000 m3/h.
Immediately after nebulization at T0, all agar plates were
totally invaded by fungal colonies (n > 258 colonies), in-
dicating a high density of Aspergillus conidia in the air.
This was considered to be the maximum airborne contam-
ination (100%). When the AirLyse air purifier was off, the
Aspergillus conidia density in the air decreased linearly with
time: 57% at 15min, 42% at 30min, and still detectable 1 h
after aerosolization (22.8% of initial inocula; Fig. 2). When
the AirLyse system was operating at 500 m3/h, the conidia
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density in the air decreased by 1 log10 in 7 min, 2 log10
in 14 min, and 5 log10 in 34 min. Elimination of 95% of
conidia in the air was obtained in 18 min at 500 m3/h and
600 m3/h and in <16 min at 1000 m3/h. At all airflow rates
tested, 99.99% of conidia were eliminated in <30 min. Af-
ter restarting the fans at the end of each experiment, there
was no substantial increase in conidia detection (from 0
CFU/200 l to 0 after activation of the fans for both 500m3/h
and 600 m3/h, and from 0 to 4 for 1000 m3/h; Fig. 2).
There was no significant difference between the λ values
for the different rates of airflow through the AirLyse purifier
(P > 0.05), indicating that the decontamination kinetics
did not differ according to airflow speed. Conversely, λ
values differed significantly between the negative reference
condition and the three airflow treatments (P < 0.001).
The Solair 5350 portable particle counter was used to
enumerate airborne particles smaller than 1 µm. The counts
decreased by 80.6%, 88.6%, and 88.6% when the AirLyse
purifier was on at 500, 600, and 1000 m3/h, respectively,
whereas the decrease was 45% when the unit was off. At
the end of the experiment, the airborne particle count was
lowest for the airflow treatment set at 1000 m3/h: 357,738
counted particles >1 µm vs. 812,590 when the air purifier
was off.
Discussion
Aspergillus fumigatus is a highly resistant fungus that con-
taminates air and can cause lethal infection in immunocom-
promised individuals. Aspergillus spp. represents 1%–7%
of the total amount of fungi in the environment. Thus, air-
borne concentrations ranging from 1 to 100 conidia/m3 are
common both indoors and outdoors, and concentrations
can reach 109 conidia/m3 in specific environments such as
construction sites or work zones [23]. Consequently, ev-
eryone inhales conidia daily, and eradication of A. fumiga-
tus from the immediate environment of susceptible patients
would be extremely beneficial [24]. Indeed, the control of
airborne microorganisms is a major issue in hospitals and
other healthcare facilities, especially during periods of con-
struction or demolition [25].
Although some air-cleaning systems, such as HEPA fil-
ters [11], decrease levels of microbiological contamination,
several studies have revealed that a wide range of miscel-
laneous bacteria, including species potentially involved in
human infections, may be retained on filters and subse-
quently released back into the filtered air [13]. Recently,
new air-treatment devices have been developed to address
this issue. Some of these devices incorporate three processes,
each of which is independently lethal to microorganisms
[26]. Airborne particles are first crashed onto a rigid three-
dimensional nonocclusive self-cleaning medium, generating
a physical stress [16]; they are simultaneously exposed to
germicidal UVC irradiation with a reactor, allowing for a
prolonged exposure; and finally, the contaminants are ex-
posed to heterogeneous photocatalysis. The combination of
these three treatments allows effective air purification [27].
We assessed the performance of an innovative mobile
air purifier that is based on photocatalysis in conditions of
massive air contamination by A. fumigatus. We developed
an experimental model of fungal contamination in which
aerosolization, homogenization, and sampling were stan-
dardized. The experimental room was 60 m3, similar to
that of a standard hospital room. The walls were smooth,
which minimized particle retention and facilitated cleaning.
The air was sampled at a height of 1.2 m above the floor,
corresponding to the average height at which air is generally
inhaled by patients who are in bed, sitting, or standing. The
mycological count results were entirely consistent between
the four sites in the room that were tested at every sampling
time. Indeed, the intraclass correlation coefficients were, in
all instances, >0.987 (where 1.0 indicates identical results),
demonstrating the reliability of the sampling technique.
Conidia are more resistant than vegetative forms, largely
because of their thick cell walls [28]. Nevertheless, we
showed that they were effectively eliminated by the AirLyse
air purifier. In spite of the extreme conditions of a saturated
atmosphere and the massive dose of A. fumigatus, the de-
vice rapidly and completely purged the contaminant from
the air. The mycological findings for sequential air samples
were confirmed by the instantaneous measurements with
the particle counter, although this enumerated all airborne
particles whether or not fungal. The airflow rate through
the air purifier did not have a significant effect on its effi-
cacy, which rapidly eliminated contamination even at the
minimum operational setting (500 m3/h). Furthermore, at
low air speed, it generated less turbulence and was quieter;
this finding is of importance for the comfort of patients and
healthcare workers. Also, because the photocatalytic reac-
tion occurs at ambient temperature, the device does not lead
to overheating. Using doped fused quartz, the lamps that
are fitted to the AirLyse air purifier transmit up to 90%
of their energy at a wavelength of 254 nm, thus avoiding
ozone generation [29]. Moreover, the machine does not
show chemical potential toxicity because there have been
no release of volatile organic compounds (LSCE-CEA Lab-
oratory, data not shown).
One limitation of our experimental model is that the
room was totally sealed throughout the experiment. This is
not the case with hospital rooms, where doors are opened
frequently. To address this limitation, we reactivated the
fans at the end of each experiment; this may have resus-
pended conidia that had settled on the floor, thus mimick-
ing door opening and other movements. After reactivation
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of the fans, the measured airborne contamination did not
increase, which is consistent with the apparent total de-
struction of the contaminant. Also, one should note that
the Tween-wetted conidia used in our experimental design
could differ in their physical properties somewhat from nat-
ural aerosolization.
Aspergillus fumigatus is not the sole microorganism re-
sponsible for air-transmitted diseases. It would be use-
ful to conduct studies with other fungi (including Sce-
dosporium, Fusarium, and Pneumocystis), bacteria (partic-
ularlyMycobacterium tuberculosis complex, pneumococci,
and multidrug-resistant bacteria), and respiratory viruses,
which are emerging as the major challenge of the decade.
The AirLyse air purifier combines three nonspecific germi-
cidal processes and may be effective against all types of
contaminants [26]; our experimental model may also be
appropriate. Nevertheless, various conditions need to be
considered based on the pathogen being targeted. For in-
stance, it is difficult to produce aerosols of Staphylococcus
aureus because its colonies are usually in biofilm aggregates.
Also, it would be difficult to assess the effectiveness against
contamination by influenza virus, as this pathogen does not
grow directly on plates or in culture medium.
To conclude, our assay in an experimental space that
mimicked a hospital room showed that, even in challeng-
ing conditions, the AirLyse air purifier was able to decrease
the fungal load in the atmosphere substantially. The photo-
catalysis process used is relatively inexpensive and the sys-
tem is self-cleaning. It may be used for diverse substrates,
allowing continuous reuse; for instance, activated carbon
may be used, allowing for high photodegradation rates be-
cause of its high adsorption capacity [16]. Thus, in addition
to other approaches (eg, overpressure, HEPA, or outdoor
air ventilation rates of 6–12 volumes per hour), the mo-
bile AirLyse air purifier may provide additional cleaning
in hospital environments, substantially and rapidly reduc-
ing indoor pathogen concentrations. Such mobile devices
may therefore be an additional and convenient solution for
protected areas where susceptible patients are located and
for patients at moderate risk in conventional rooms during
hospital renovation.
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